Global Immunohistochemistry (IHC) Market - Global Forecast To 2030


Global Immunohistochemistry (IHC) Market - Global Forecast To 2030

 Category : Biotechnology

 Published: Mar-2022
 Author: SPER Analyst

According to SPER Market Research, the Immunohistochemistry Market is estimated to reach USD 5.8 billion by 2030 with a CAGR of 6.5%. The increasing prevalence of cancer, chronic diseases, swiftly increasing geriatric population, investment in diagnostic research, big companies presence; are the fuel to the expansion of the Immunohistochemistry Market.

Immunohistochemistry; is an application of monoclonal antibodies & polyclonal antibodies, used in the diagnosis of cancer particularly.

The antibodies segment & the Diagnostic applications segment dominate the major share of the product segment & application segment respectively.

Browse report overview on "Global Immunohistochemistry Market" at:

Rising demand for personalized medicine, importance of companion diagnostics, huge opportunities in the emerging economies; create opportunity for the market player in this field.

Unskilled professional, intense consolidation, patent expiry; are the challenges to this market.

The global Immunohistochemistry Market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Abcam plc, Agilent Technologies, Inc., Becton, Bio SB, Inc., Biocare Medical, LLC, Biogenex Laboratories, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioVision Inc., CANDOR Bioscience GmbH, Cell Signalling Technology, Inc., Danaher Corporation,  Diagnostic Biosystems, Inc., Dickinson and Company, Eagle Biosciences, Inc., Elabscience, Inc.,F. Hoffman-La Roche AG, Genemed Biotechnologies, Inc., Merck KGaA, Miltenyi Biotec, PerkinElmer, Inc., PHC Holdings Corporation, Rockland Immunochemicals, Inc., Sakura Finetek Japan Co., Ltd.,  Takara Bio, Inc., Thermo Fisher Scientific, Inc.

Request sample pages for Global Immunohistochemistry Market report and gain crucial industry insights that will help your business grow at:

SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for Product segment- Antibodies (Primary antibodies, Secondary antibodies), Reagents (Blocking Sera and Reagents, Chromogenic Substrates, Diluents, Fixation Reagents, Histological Stains, Organic Solvents, Other Reagents, Proteolytic Enzymes), Equipment ( Slide Scanners, Slide-staining Systems, Tissue Processing Systems, Other Equipment ), Kits ( IHC Kits for Animal tissue, IHC Kits for Human tissue) for End-Users segment- Academic & research Institutes, Hospitals & Diagnostic Laboratories, Other end users (CROs, Pharma & biopharma companies, and forensic laboratories).

This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World. 

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report. 

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson


Market Research

We are the leading, full-service global market research and consulting company.

iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]